Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation.

Jonathan Lehman, M.D., Ph.D., instructor in Medicine in the Division of Hematology/Oncology, has received a Career Development Award from LUNGevity, a nonprofit organization that provides support programs for lung cancer patients and families, public education and funding for innovative scientific research.

Lymphedema research conducted at Vanderbilt University Medical Center (VUMC) to better understand patient risk for this chronic condition and treatment responses received recognition at an international conference.

Vanderbilt University Medical Center is part of a 6-year, $4.4 million grant from the National Institutes of Health to improve the use of prescribed medication by sickle cell patients.

Members of the Vanderbilt Transplant Center staff celebrate with the 100th patient seen at the satellite pre-transplant clinic in Madison, Alabama, which opened in January.

Jeffrey Creasy, M.D., chief of Neuroradiology in Vanderbilt’s Department of Radiology and Radiological Sciences, recently participated in a three-week American Society of Neuroradiology (ASNR) International Outreach Professorship to South Africa.

As part of the VU/VUMC transition, all Medical Center employees and their families may continue to utilize the Recreation and Wellness Center for current membership rates through the end of 2016.